News Updates
More Articles
- The Importance of Consulting Children and Parents in Clinical Trial Design
- Patient Engagement (PE) and Patient Experience Data (PED)
- Have Your Say: ICH Draft Scientific Guideline E22 on Patient Preference Studies Published for Comments
- Global IDMP Standards Can Strengthen the Drug Supply Chain and Improve Lives
- Regulatory-Ready AI: Modernization and Compliance Can Co-Exist in Clinical Research
Regulatory-Ready AI: Modernization and Compliance Can Co-Exist in Clinical Research
Regulatory-Ready AI: Modernization and Compliance Can Co-Exist in Clinical Research
New guidance from EMA and US FDA make one theme clear: AI must be explainable and traceable—and accountability, lifecycle monitoring, and data provenance are essential requirements—when AI informs regulatory decisions.
×
